T. Rowe Price Associates
GDRX icon

T. Rowe Price Associates’s GoodRx Holdings GDRX Stock Holding History

T. Rowe Price Associates’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76K Sell
38,432
-404,236
-91% -$948K ﹤0.01% 3035
2025
Q4 		$1.2M Buy
442,668
+51,243
+13% +$168K ﹤0.01% 2000
2025
Q3 		$1.66M Buy
391,425
+134,771
+53% +$592K ﹤0.01% 1817
2025
Q2 		$1.28M Buy
256,654
+3,140
+1% +$13.6K ﹤0.01% 1862
2025
Q1 		$1.12M Sell
253,514
-1,678
-0.7% -$7.88K ﹤0.01% 1899
2024
Q4 		$1.19M Buy
255,192
+56,522
+28% +$311K ﹤0.01% 1895
2024
Q3 		$1.38M Buy
198,670
+180,370
+986% +$1.42M ﹤0.01% 1818
2024
Q2 		$143K Buy
18,300
+4,000
+28% +$29.6K ﹤0.01% 2677
2024
Q1 		$102K Hold
14,300
– – ﹤0.01% 2779
2023
Q4 		$96K Hold
14,300
– – ﹤0.01% 2722
2023
Q3 		$81K Sell
14,300
-4,700
-25% -$31.3K ﹤0.01% 2702
2023
Q2 		$105K Hold
19,000
– – ﹤0.01% 2694
2023
Q1 		$119K Sell
19,000
-6,100
-24% -$34K ﹤0.01% 2651
2022
Q4 		$117K Hold
25,100
– – ﹤0.01% 2683
2022
Q3 		$118K Buy
25,100
+1,000
+4% +$6.3K ﹤0.01% 2690
2022
Q2 		$143K Buy
24,100
+9,500
+65% +$106K ﹤0.01% 2680
2022
Q1 		$282K Buy
14,600
+5,300
+57% +$122K ﹤0.01% 2572
2021
Q4 		$304K Sell
9,300
-1,200
-11% -$48.3K ﹤0.01% 2590
2021
Q3 		$431K Buy
10,500
+3,600
+52% +$131K ﹤0.01% 2440
2021
Q2 		$248K Sell
6,900
-600
-8% -$22.1K ﹤0.01% 2646
2021
Q1 		$293K Buy
+7,500
New +$337K ﹤0.01% 2573
2020
Q4 		– Sell
-2,250,000
Closed -$125M – 2689
2020
Q3 		$125M Buy
+2,250,000
New +$119M 0.01% 595

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

T. Rowe Price Associates's GDRX Position: Q1 2026 in Review

T. Rowe Price Associates reduced its GoodRx Holdings (GDRX) stake by 91% in Q1 2026, selling an estimated $948K and leaving 38,432 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

T. Rowe Price Associates first reported a position in GDRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $125M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • T. Rowe Price Associates held 38,432 shares of GoodRx Holdings worth $76K as of Q1 2026.
  • T. Rowe Price Associates sold 404,236 GoodRx Holdings shares in Q1 2026, an estimated $948K.
  • GoodRx Holdings made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3035 holding.
  • T. Rowe Price Associates first reported a position in GoodRx Holdings in Q3 2020 and has held it in 22 quarters since.
  • T. Rowe Price Associates's GoodRx Holdings position peaked at $125M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.